Stigma, Taboo, and Public Health: A Sociological and Bioecological Approach to the Use of Performance and Image-Enhancing Drugs
DOI:
https://doi.org/10.14738/assrj.1201.18241Keywords:
Behavioral Sciences, Performance-Enhancing Substances, Public HealthAbstract
Background: This article provides an interdisciplinary review of performance-enhancing and image-enhancing drugs (PEDs) through sociological and bioecological lenses. The analysis reveals a growing and complex trend of PED use among recreational users. Methods: Utilizing Bronfenbrenner’s bioecological theory along with covering books, reports, anti-doping notes, observational studies and systematic reviews, this review explores how different pressures influence PED use. Goffman’s concept of stigma highlights the marginalization PED users encounter, as they are often associated with cheating or health risks. Findings: The article examines how different systems spread unrealistic body ideals, which intensifies pressures on individuals to normalize PED use. The western cultural dynamic connects PED use to both physical aspirations and deeper self-worth issues related to body image and it is the duty of healthcare professionals not only to refuse such prescriptions but also to actively engage in prevention and public awareness efforts regarding the dangers of PEDs. Interpretation: Emphasizing the need for an empathetic yet firm medical approach, the article advocates for healthcare professionals to engage openly with PED users to foster supportive dialogues with. Such engagement is crucial for effective public health interventions that can address both the physical and psychological risks of PED use, ultimately contributing to a more health-centered societal perspective on performance and body image. In conclusion, this article emphasizes the urgent need to reframe the conversation around PEDs, recognizing their complex social underpinnings to better approach affected individuals.
References
Baum Z. The science behind performance-enhancing drugs [Internet]. American Chemical Society; 2021 [cited 2024 Nov 16]. Available from: https://www.cas.org/resources/cas-insights/science-behindperformance-enhancing-drugs.
Smith T, Fedoruk M, Eichner A. Performance-Enhancing Drug Use in Recreational Athletes. Am Fam Physician. 2021 Feb 15 [cited 2024 Nov 16];103(4):203–4. Available from: https://www.aafp.org/pubs/afp/issues/2021/0215/p203.html. 270
World Anti-Doping Code International Standard Prohibited List 2024 [Internet]. World Anti-Doping Agency. 2024 Jan 01 [cited 2024 Nov 16]. Available from: https://www.wadaama.org/sites/default/files/2023-09/2024list_en_final_22_september_2023.pdf.
Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014 May [cited 2024 Nov 16];24(5):383–98. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1047279714000398?via%3Dihub.
Pope HG, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolicandrogenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2014 [cited 2024 Nov 16];23(4):371–7. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3961570/.
Girardi PG, Lopes SC, Terres I da S. A prevalência do uso de esteroides anabolizantes no Brasil - uma revisão sistemática. 2023 Jul 20 [cited 2024 Nov 16]; Available from: https://www.unidavi.edu.br/bibliotecatrabalhos/consultartrabalho/trabalho/88763/detalhe.
Shimko KM, Piatkowski T, Thomas K V, et al. Performance- and image-enhancing drug use in the community: use prevalence, user demographics and the potential role of wastewater-based epidemiology. J Hazard Mater. 2021 Oct 5 [cited 2024 Nov 16]; 419:126340. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0304389421013042?via%3Dihub.
Bronfenbrenner, U. The Ecology of Human Development: Experiments by Nature and Design. Cambridge, MA and London, England: Harvard University Press; 1979. 352 p. Available from: https://doi.org/10.4159/9780674028845.
Madigan DJ, Stoeber J, Passfield L. Perfectionism and attitudes towards doping in junior athletes. J Sports Sci. 2016 [cited 2024 Nov 16];34(8):700–6. Available from: https://doi.org/10.1080/02640414.2015.1068441.
Wiefferink CH, Detmar SB, Coumans B, Vogels T, Paulussen TGW. Social psychological determinants of the use of performance-enhancing drugs by gym users. Health Educ Res. 2008 Feb [cited 2024 Nov 16];23(1):70–80. Available from: https://doi.org/10.1093/her/cym004.
Pacilli MG, Spaccatini F, Roccato M. “You Look So Beautiful… But Why Are You So Distressed?”: The Negative Effects of Appearance Compliments on the Psychological Well-being of Individuals in the Workplace. Sex Cult. 2023 Apr 9 [cited 2024 Nov 16] ;27(2):659–73. Available from: https://doi.org/10.1007/s12119-022-10033-3.
Kanayama G, Pope HG. History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol. 2018 Mar 15 [cited 2024 Nov 16];464:4–13. Available from: https://doi.org/10.1016/j.mce.2017.02.039.
Dixon SJ. Statista. 2024 [cited 2024 Nov 16]. Daily time spent on social networking by internet users worldwide from 2012 to 2024. Available from: https://www.statista.com/statistics/433871/daily-socialmedia-usage-worldwide/.
Powell J, Pring T. The impact of social media influencers on health outcomes: Systematic review. Soc Sci Med. 2024 Jan [cited 2024 Nov 16];340:116472. Available from: https://www.sciencedirect.com/science/article/pii/S0277953623008298?via%3Dihub.
Otterbring T, Ringler C, Sirianni NJ, Gustafsson A. The Abercrombie & Fitch Effect: The Impact of Physical Dominance on Male Customers’ Status-Signaling Consumption. Journal of Marketing Research. 2018 Feb 01 [cited 2024 Dec 3];55(1):69–79. Available from: https://journals.sagepub.com/doi/full/10.1509/jmr.15.0247. 271
Goffman E. Stigma: Notes on the Management of Spoiled Identity. New Jersey: Prentice-Hall; 1963. 147 p.
Robinson E, Calvino J, Litchfield M, Lawrence M, Darren W. UK Anti-Doping. 2020 [cited 2024 Nov 16]. Webinar recap: Is it taboo? Coaches, athletes and anti-doping. Available from: https://www.ukad.org.uk/news/webinar-recap-it-taboo-coaches-athletes-and-anti-doping.
Dimitrov R, Jelen A, L’Etang J. Taboos in health communication: Stigma, silence and voice. Public Relations Inquiry. 2022 Jan 21 [cited 2024 Nov 16];11(1):3–35. Available from: https://doi.org/10.1177/2046147X211067002.
Belfiore CI, Galofaro V, Cotroneo D, et al. A Multi-Level Analysis of Biological, Social, and Psychological Determinants of Substance Use Disorder and Co-Occurring Mental Health Outcomes. Psychoactives. 2024 Apr 8 [cited 2024 Nov 16];3(2):194–214. Available from: https://doi.org/10.3390/psychoactives3020013.
Pope HG, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement. Endocr Rev. 2014 Jun 1 [cited 2024 Nov 16];35(3):341–75. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4026349/.
Rahnema CD, Crosnoe LE, Kim ED. Designer steroids – over‐the‐counter supplements and their androgenic component: review of an increasing problem. Andrology. 2015 Mar 13 [cited 2024 Nov 16];3(2):150–5. Available from: https://doi.org/10.1111/andr.307.
Ganson KT, Nguyen L, Ali ARH, et al. Associations between social media use, fitness- and weight-related online content, and use of legal appearance- and performance-enhancing drugs and substances. Eat Behav. 2023 Apr [cited 2024 Nov 16];49:101736. Available from: https://doi.org/10.1016/j.eatbeh.2023.101736.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Luis Felipe Duarte Coutinho, Leonardo Vaz do Nascimento-Salgado, Valentina de Monteiro-Bontempo, Roberta Rayra Martins-Chaves
This work is licensed under a Creative Commons Attribution 4.0 International License.
